PROJECT 3: Respiratory syncytial virus (RSV) is the leading cause of respiratory failure in young children and severe RSV bronchiolitis has been identified as risk factor for the subsequent development of asthma in children. Currently, there is no effective vaccine for RSV and pharmacologic treatment is far from optimal. Development of new therapeutic agents is critical to reduce the morbidity and mortality from this important pathogen, and to perhaps modify the risk of childhood asthma. Our preliminary data suggest that prostaglandin (PG) 12 is a novel therapeutic target for RSV. In a well characterized murine model of RSV infection, we reported that transgenic mice that constitutively overexpress PGI synthase (PGIS) were significantly protected from RSV-induced illness. In addition, we found that mice which cannot signal through the PGI2 receptor (IP) had significantly exacerbated weight loss and delayed recovery after RSV infection. Further, in a collaborative study of infants admitted with RSV bronchiolitis, we found that a functional polymorphism in the promoter region of the PGI synthase (PGIS) gene was associated with an increase in the urinary PGI2 metabolite and less severe bronchiolitis. These data strongly suggest that PGI2 and IP signaling protect against RSV-induced disease. The long term objective of this application are to define role of PGI2 in RSV-induced airway pathophysiology and the mechanism by which PGI2 protects against RSV-induced illness. We have isolated an RSV strain (01/2-20) from an infant with bronchiolitis that induced airway responsiveness, airway mucus expression, and high levels of lung IL-13 protein in mice.
In aim 1, we hypothesize that PGI2 and IP signaling protects against RSV 01/2-20 -induced airway responsiveness, inflammation, and pathology. We also have preliminary data which reveals that PGI2 selectively downregulates bone marrow derived dendritic cell and macrophage expression of TLR4, a pattern recognition receptor that is activated by the RSV F protein.
In aim 2 we hypothesize that PGI2 modulates RSV-induced immunopathology in a TLR4-dependent manner. The proposed studies may result in a novel, effective therapy for RSV bronchiolitis.

Public Health Relevance

RSV is the leading cause of bronchiolitis and causes >100,000 infant hopsitalizations in the US each year. Studies have also revealed that severe RSV infection in infancy is associated with the later development of childhood asthma. This application will examine the role of PGI2 in RSV-induced airway disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
1U19AI095227-01
Application #
8196529
Study Section
Special Emphasis Panel (ZAI1-PA-I (M1))
Project Start
2011-08-01
Project End
2016-07-31
Budget Start
2011-08-01
Budget End
2012-07-31
Support Year
1
Fiscal Year
2011
Total Cost
$254,482
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Wurth, Mark A; Hadadianpour, Azadeh; Horvath, Dennis J et al. (2018) Human IgE mAbs define variability in commercial Aspergillus extract allergen composition. JCI Insight 3:
Toki, Shinji; Zhou, Weisong; Goleniewska, Kasia et al. (2018) Endogenous PGI2 signaling through IP inhibits neutrophilic lung inflammation in LPS-induced acute lung injury mice model. Prostaglandins Other Lipid Mediat 136:33-43
Bloodworth, Melissa H; Rusznak, Mark; Bastarache, Lisa et al. (2018) Association of ST2 polymorphisms with atopy, asthma, and leukemia. J Allergy Clin Immunol 142:991-993.e3
Brunwasser, Steven M; Gebretsadik, Tebeb; Gold, Diane R et al. (2018) A new model of wheezing severity in young children using the validated ISAAC wheezing module: A latent variable approach with validation in independent cohorts. PLoS One 13:e0194739
Celada, Lindsay J; Kropski, Jonathan A; Herazo-Maya, Jose D et al. (2018) PD-1 up-regulation on CD4+ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-?1 production. Sci Transl Med 10:
Donovan, Brittney M; Ryckman, Kelli K; Breheny, Patrick J et al. (2018) Association of newborn screening metabolites with risk of wheezing in childhood. Pediatr Res 84:619-624
Turi, Kedir N; Shankar, Jyoti; Anderson, Larry J et al. (2018) Infant Viral Respiratory Infection Nasal Immune-Response Patterns and Their Association with Subsequent Childhood Recurrent Wheeze. Am J Respir Crit Care Med 198:1064-1073
Stone Jr, Cosby A; McEvoy, Cindy T; Aschner, Judy L et al. (2018) Update on Vitamin E and Its Potential Role in Preventing or Treating Bronchopulmonary Dysplasia. Neonatology 113:366-378
Tashkin, Donald P; Peebles Jr, R Stokes (2018) Controversies in Allergy: Is Asthma Chronic Obstructive Pulmonary Disease Overlap a Distinct Syndrome That Changes Treatment and Patient Outcomes? J Allergy Clin Immunol Pract :
Stone Jr, Cosby A; Hemler, Jonathan A; Commins, Scott P et al. (2018) Reply. J Allergy Clin Immunol 141:1957-1958

Showing the most recent 10 out of 111 publications